Why in news?
During a recent session of the Rajya Sabha, the Minister of State for Health and Family Welfare provided an update on India’s efforts to eliminate leprosy. He explained that the National Leprosy Eradication Programme (NLEP) continues to offer free diagnosis and treatment across the country and is adopting digital surveillance tools. The announcement underscored the government’s determination to reduce new infections and the stigma associated with this long‑standing disease.
Background
Leprosy, or Hansen’s disease, is a chronic infectious illness caused by the bacterium Mycobacterium leprae. It mainly affects the skin and peripheral nerves and, if left untreated, can lead to disability and social ostracism. In the 1980s India accounted for a large share of the world’s leprosy burden, prompting the government to launch the NLEP in 1983. The programme adopted multidrug therapy recommended by the World Health Organization and has since reduced prevalence dramatically.
The NLEP is now a centrally sponsored scheme under the National Health Mission. It aims to interrupt transmission by ensuring early detection, complete treatment and care for persons affected by leprosy. Services – including diagnosis, drug therapy and rehabilitation – are provided free of charge through public health facilities. The programme also funds training for health workers, awareness campaigns and research, and encourages states to integrate leprosy control with general health services.
Strategies and objectives
- Early case detection: Health workers conduct Leprosy Case Detection Campaigns and Focused Leprosy Campaigns in high‑risk areas to identify undetected cases.
- Community surveillance: Accredited Social Health Activists (ASHAs) and volunteers monitor communities for suspicious skin lesions and refer individuals for diagnosis.
- Treatment and follow‑up: Multi‑drug therapy is provided at no cost. Disability prevention and post‑treatment care are offered to minimise complications.
- Digital tools: Platforms such as Nikusth 2.0 record case data, track treatment progress and facilitate timely reporting.
- Awareness and stigma reduction: The Sparsh Leprosy Awareness Campaign and community meetings educate people about symptoms and emphasise that early treatment prevents disability.
- Objectives: The programme seeks to reduce the prevalence rate below 1 case per 10,000 population at the district level, cut the proportion of new cases with visible deformities, ensure zero disability among child cases and eliminate discrimination against persons affected by leprosy.
Significance
- Public health impact: India has witnessed a steep decline in leprosy prevalence thanks to sustained action, though continued vigilance is needed because of the disease’s long incubation period.
- Equitable access: Free diagnosis and treatment ensure that even the poorest patients receive care, reducing preventable disability.
- Integration with other programmes: Linking leprosy services with general health systems allows for efficient use of resources and makes care more accessible.
- Stigma reduction: Awareness campaigns encourage early reporting and combat misconceptions that still surround leprosy in many communities.
Conclusion
The National Leprosy Eradication Programme has transformed India’s response to a once‑widespread disease. By focusing on early detection, free treatment and social inclusion, the programme moves the country closer to its goal of zero leprosy. Continued funding, digital innovation and community engagement will be essential to eliminate remaining pockets of infection and stigma.
Sources: PIB
